These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 2234057

  • 1. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
    Teyton L, O'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, Peterson PA.
    Nature; 1990 Nov 01; 348(6296):39-44. PubMed ID: 2234057
    [Abstract] [Full Text] [Related]

  • 2. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO, LaVaute T, Pinet V, Jaraquemada D.
    J Immunol; 1994 Aug 15; 153(4):1487-94. PubMed ID: 8046228
    [Abstract] [Full Text] [Related]

  • 3. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41.
    Peterson M, Miller J.
    Nature; 1992 Jun 18; 357(6379):596-8. PubMed ID: 1608470
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C, van Endert P, Koch N.
    J Immunol; 1995 Feb 01; 154(3):1048-56. PubMed ID: 7822782
    [Abstract] [Full Text] [Related]

  • 7. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S, Humphreys RE.
    Eur J Immunol; 1995 Jun 01; 25(6):1693-702. PubMed ID: 7614997
    [Abstract] [Full Text] [Related]

  • 8. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L, Ullrich SJ, Appella E, Fuchs S.
    Nature; 1990 Jul 05; 346(6279):63-6. PubMed ID: 2366863
    [Abstract] [Full Text] [Related]

  • 9. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K, Miller J.
    J Immunol; 1995 Jul 15; 155(2):630-43. PubMed ID: 7608541
    [Abstract] [Full Text] [Related]

  • 10. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL, Smith KD, Lutz CT.
    J Immunol; 1996 Nov 15; 157(10):4503-10. PubMed ID: 8906828
    [Abstract] [Full Text] [Related]

  • 11. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
    Schafer PH, Green JM, Malapati S, Gu L, Pierce SK.
    J Immunol; 1996 Dec 15; 157(12):5487-95. PubMed ID: 8955198
    [Abstract] [Full Text] [Related]

  • 12. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens.
    Bikoff EK.
    J Immunol; 1992 Jul 01; 149(1):1-8. PubMed ID: 1318896
    [Abstract] [Full Text] [Related]

  • 13. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L, Guéry JC, Fuchs S, Ortiz-Navarrete V, Hämmerling GJ, Momburg F.
    J Immunol; 1993 Oct 01; 151(7):3576-86. PubMed ID: 7690807
    [Abstract] [Full Text] [Related]

  • 14. MHC II and the endocytic pathway: regulation by invariant chain.
    Landsverk OJ, Bakke O, Gregers TF.
    Scand J Immunol; 2009 Sep 01; 70(3):184-93. PubMed ID: 19703008
    [Abstract] [Full Text] [Related]

  • 15. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
    Dodi AI, Brett S, Nordeng T, Sidhu S, Batchelor RJ, Lombardi G, Bakke O, Lechler RI.
    Eur J Immunol; 1994 Jul 01; 24(7):1632-9. PubMed ID: 8026524
    [Abstract] [Full Text] [Related]

  • 16. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L, Kovats S, Eastman S, Rudensky AY.
    J Immunol; 1996 Mar 15; 156(6):2196 - 2204. PubMed ID: 8690909
    [Abstract] [Full Text] [Related]

  • 17. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA, Chaturvedi P, Lee-Chan EC, Rider BJ, Singh B.
    J Immunol; 1996 Jun 01; 156(11):4232-9. PubMed ID: 8666792
    [Abstract] [Full Text] [Related]

  • 18. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.
    Roche PA, Cresswell P.
    Nature; 1990 Jun 14; 345(6276):615-8. PubMed ID: 2190094
    [Abstract] [Full Text] [Related]

  • 19. Invariant chain influences the immunological recognition of MHC class II molecules.
    Peterson M, Miller J.
    Nature; 1990 May 10; 345(6271):172-4. PubMed ID: 1692393
    [Abstract] [Full Text] [Related]

  • 20. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
    Vogt AB, Stern LJ, Amshoff C, Dobberstein B, Hämmerling GJ, Kropshofer H.
    J Immunol; 1995 Nov 15; 155(10):4757-65. PubMed ID: 7594477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.